Evidence map›Paper›PMID 40032765›Full record

ArticleCellular and molecular life sciences : CMLS2025

Nuclear translocation of CDK5RAP3 regulated by NXF3 promotes the progression of gastric cancer.

Cheng Zhang, Dongyang Wang, Yuguang Shen, Yuanruohan Zhang, Jiahua Liu

Abstract read
In one paragraph

Article in Cellular and molecular life sciences : CMLS, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Cheng ZhangDepartment of Gastrointestinal Surgery, Renji Hospital Affiliated, Shanghai Jiaotong University School of Medicine, No.160, Pujian Road, Pudong New Area, Shanghai, 200127, China.
Dongyang WangDepartment of Gastrointestinal Surgery, Renji Hospital Affiliated, Shanghai Jiaotong University School of Medicine, No.160, Pujian Road, Pudong New Area, Shanghai, 200127, China.
Yuguang ShenDepartment of Gastrointestinal Surgery, Renji Hospital Affiliated, Shanghai Jiaotong University School of Medicine, No.160, Pujian Road, Pudong New Area, Shanghai, 200127, China.
Yuanruohan ZhangDepartment of Gastrointestinal Surgery, Renji Hospital Affiliated, Shanghai Jiaotong University School of Medicine, No.160, Pujian Road, Pudong New Area, Shanghai, 200127, China.
Jiahua LiuDepartment of Gastrointestinal Surgery, Renji Hospital Affiliated, Shanghai Jiaotong University School of Medicine, No.160, Pujian Road, Pudong New Area, Shanghai, 200127, China. 18487182139@163.com.ORCID http://orcid.org/0000-0001-5834-3362

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundNuclear-cytoplasmic transport proteins (NCTPs) impact the transport of proteins and RNA molecules between the nucleus and cytoplasm in tumor cells, making them promising targets for cancer therapy. Currently, the molecular mechanism and function of Nuclear RNA export factor 3 (NXF3) in gastric cancer (GC) remains unclear.

methodsWe used Univariate Cox regression analysis and LASSO regression analysis, Receiver Operating Characteristic (ROC) curves to construct and evaluate a NCTP prognosis risk scoring model (NCTP model). Moreover, we identified the key NCTP (NXF3) affecting GC through differential expression and prognosis analysis. Subsequently, we introduced NXF3 shRNA into GC cells to investigate the impact of NXF3 on the cell proliferation, cell migration, invasion, and cell cycle and apoptosis and tumor growth by CCK-8 assay, transwell, wound healing assay, Flow cytometry, and nude mice subcutaneous tumor in vitro and in vivo. Furthermore, we investigated the key molecules influenced by NXF3 through piRNA-Seq, RNA-Seq, RIP-Seq, IP-MS, and Nuclear-cytoplasmic transcriptomics.

resultsWe constructed a prognostic risk model related to 3 NCTPs, including NXF3, GLE1 and RANGAP. The NCTP model effectively predicts the prognosis of GC patients. The low-risk group exhibited a significantly higher overall survival rate than that of the high-risk group. Notably, NXF3 is identified as a crucial NCTP in GC, and its high expression is associated with poor prognosis of GC patients. Knocking down of NXF3 significantly inhibited the proliferation, invasion, migration, cell cycle, tumor growth and induced cell apoptosis of GC cells in vitro and in vivo. Mechanistically, NXF3 modulates the cell cycle, cellular senescence related oncogenic pathways via piRNA-target network. Specifically, our findings highlighted several piRNA-related signaling pathways in GC, such as piRNA_3457319-CCND1/CDKN1A-p53, piRNA_2847077-TGFB3/TGFBR2-Cellular senescence, piRNA_448895-IGF1/PDGFRA/ACTB/MAP2K6-Rap1. Moreover, NXF3 was shown to facilitate the nuclear export of CDK5RAP3 mRNA, thereby promoting cell cycle progression and increasing cancer cell proliferation in gastric cancer.

conclusionOur study demonstrates that NXF3 modulates cell cycle progression and promotes gastric cancer development through piRNA-related pathways and the nuclear export of CDK5RAP3 mRNA. Targeting NXF3 represents a promising strategy for developing novel therapeutic approaches for gastric cancer.

Indexed as

Cell Cycle ProteinsCell NucleusIntracellular Signaling Peptides and ProteinsNerve Tissue ProteinsNucleocytoplasmic Transport ProteinsRNA-Binding ProteinsStomach NeoplasmsActive Transport, Cell NucleusAnimalsApoptosisCell Line, TumorCell MovementCell ProliferationDisease ProgressionFemaleGene Expression Regulation, NeoplasticCDK5RAP3 protein, humanCell Cycle ProteinsIntracellular Signaling Peptides and ProteinsNerve Tissue ProteinsNucleocytoplasmic Transport ProteinsRNA-Binding ProteinsTumor Suppressor ProteinsCDK5RAP3Cell cycleGastric cancerNuclear-cytoplasmic transportNXF3PiRNA

Identifiers

PMID40032765
PMCPMC11876495

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.